Rapportkommentar Q1 2024 Nanologica AB publ
26 April, 2024
Vd Andreas Bhagwani kommenterar Nanologicas kvartalsrapport för första kvartalet 2024.
Latest news
Categories
News archive
CEO Comment Q1 2024
26 April, 2024
The year has started both positively and negatively. On a positive note, we have started delivering chromatography media to customers and we achieved net sales of MSEK 5 in the first quarter. This is the company’s highest sales of chromatography products in a single quarter to date and in line with the expectations of a a sharp increase in sales of chromatography media in 2024. At the same time, the work of optimizing the production
CEO Comment from Annual Report 2023
22 March, 2024
2023 has been marked by geopolitical tensions and macroeconomic uncertainty. Like most others, Nanologica has been affected by this and we have had to prioritize our resources. On the other hand, we operate in a market segment that is virtually insensitive to economic cycles. We expect a commercial breakthrough in the near future and have a clear growth strategy for how we can capitalize on the strong market growth that exists in drugs for the
Nanologica’s Annual Report for 2023 Has Been Published
22 March, 2024
The annual report in Swedish and a translation in English is available on www.nanologica.com in a pdf format. The official original version of the annual report is prepared in Swedish in the European Single Electronic Format (ESEF). Swedish: https://nanologica.com/category/finansiella-rapporter/ English translation: https://nanologica.com/category/financial-reports/
Subscription for Shares in Nanologica´s Rights Issue
28 February, 2024
The subscription period for shares in Nanologica´s rights issue has now started. For information on how to subscribe, please see below links: Swedish: https://nanologica.com/foretradesemission-2024/ English: https://nanologica.com/rights-issue-2024/ Subscription period: 28 Feb – 13 Mar 2024 Subscription price: SEK 6.75
Nanologica offentliggör prospekt avseende företrädesemission
23 February, 2024
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SINGAPORE, SYDAFRIKA, ELLER I NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDET, PUBLICERINGEN ELLER DISTRIBUTIONEN AV DETTA PRESSMEDDELANDE SKULLE VARA OLAGLIG, VARA FÖREMÅL FÖR LEGALA RESTRIKTIONER ELLER SKULLE KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER. Nanologica AB (publ) (”Nanologica” eller ”Bolaget”) offentliggör prospekt med anledning av den företrädesemission av aktier motsvarande cirka 54,2 MSEK som beslutades av styrelsen den 30 januari